News

With evidence that at least 50% of glaucoma is undiagnosed, strategies are needed to identify these individuals and assure they receive proper care. Experience so far with the American Academy of Ophthalmology’s EyeSmart EyeCheck screening initiative indicates it is a successful model for approaching the problem of undiagnosed eye disease among at-risk populations in the United States.

Profile of democracy

Observations of modern American political science seen from the past

The use of microplasmin (ocriplasmin; Jetrea, ThromboGenics) was evaluated in the Microplasmin for Children (MIC) trial for use in pediatric patients. The results are forthcoming.

Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. to become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain.

Lorenz E. Zimmerman, MD, the founder of modern ophthalmic pathology, who spent his career studying diseases of the eye, died March 16, 2013 of complications from an infection.

The FDA has approved a new drug application for phenylephrine hydrochloride ophthalmic solution, USP 2.5% and 10% (Paragon BioTeck Inc.) to dilate the pupil.